We provide a forecast for its core product, ValveClamp and ValveClasp, as well as the pre-money valuation for Shanghai Hanyu. Ke Yan, CFA, FRM 251Views Share bullish•Lepu Scientech Medical Technology (Shanghai) •10 Aug 2021 09:04 ...
The crucial point seems to be "The large impact of the decrease in motorcycle sales in emerging nations due to changes in the market environment is anticipated to erode the initial forecast for full-year net sales, operating income and ordinary income," which is mentioned only in passing in ...